dx 9065a has been researched along with epidermal growth factor in 1 studies
| Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 92 | 7 | 8 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avril, C; Bono, F; Dol, F; Herault, J; Herbert, J; Mares, A; Schaeffer, P | 1 |
1 other study(ies) available for dx 9065a and epidermal growth factor
| Article | Year |
|---|---|
Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.
Topics: Animals; Antibodies, Blocking; Blotting, Western; Carotid Arteries; Carotid Artery Injuries; Cells, Cultured; Endothelium, Vascular; Epidermal Growth Factor; Factor X; Factor Xa; Factor Xa Inhibitors; Hemostatics; Homeostasis; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Muscle, Smooth; Naphthalenes; Peptides; Phosphatidylinositols; Platelet-Derived Growth Factor; Propionates; Protein Binding; Rabbits; Receptors, Cell Surface; Serine Proteinase Inhibitors; Survivin; Thrombin | 1998 |